The COVID-19 pandemic forced the pharmaceutical industry to do what once seemed impossible: compress launch cycles that traditionally stretched over a decade into mere months.
The urgency of the crisis redefined what “readiness” meant, with organizations working across functions,
Read More
Lessons from COVID-19: How Agile Governance is Transforming Pharmaceutical Launch Readiness































































